CARLA LEE: Open Payments
NPI 1063170199 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $177
Food & beverage: $154Consulting: $23
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Octapharma USA, Inc. | 1 | $26 |
| ADMA BioManufacturing LLC | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $19 |
Products named: ULTOMIRIS, HYQVIA, PANZYGA, AMVUTTRA, Gamunex-C.
Industry payments across IN — which companies pay providers there.
